Naturasil
- Manufacturer
- Nature's Innovation
- Effective date
- 2021-01-14
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 3
- Source
- full-release
- Hydrated at
- 2026-06-01 02:14:09
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Drug Facts
Active Ingredients
Phosphoricum Acidum (Phosphoric Acid)
6X HPUS
DESCRIPTION SECTION
The letters HPUS indicate the component(s) in this product is (are) officially monographed in the Homeopathic Pharmacopeia of the United States.
OTC - PURPOSE SECTION
Purpose
Blood Boil Relief
INDICATIONS & USAGE SECTION
Uses: Symptomatic treatment of cherry angiomas.
WARNINGS SECTION
Warnings:For external use only.
OTC - ASK DOCTOR SECTION
Ask a doctor before use if pregnant or nursing.
OTHER SAFETY INFORMATION
Don't apply to eye or eye area.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children.
OTC - DO NOT USE SECTION
Do not use if tamper evident seal is broken.
OTHER SAFETY INFORMATION
In case of ingestion call Poison Control Center hotline immediately at 1-800-222-1222.
DOSAGE & ADMINISTRATION SECTION
Directions: Apply a few drops to affected area 2-3 times per day. Redness will subside with continued use over 2-4 weeks or more. Not recommended for children 2-10 years of age. Some individuals may be sensitive to essential oils. Skin test for tolerability. If irritation or reaction occurs, discontinue use.
INACTIVE INGREDIENT SECTION
Inactive Ingredients: Chamomile Flower Oil, Cymbopogon Martini Leaf Oil, Isopropyl Alcohol, Lavender Oil, Orange Peel Oil, Pelargonium Leaf Oil.
OTC - QUESTIONS SECTION
Questions?
www.naturasil.com 1-866-371-2499
Mfd. by: Nature's Innovation, Inc., 2723 Brickton
North Dr., Buford, GA 30518 Not tested on animals.
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
100% Natural Plant Extracts
Naturasil
10ml (.34 fl. oz.)
Topical Liquid
Homeopathic Medicine
Cherry Angiomas
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 10893-120-10 | NaturasilCherry Angiomas | 1 in 1 CARTON | LIQUID | 1 | 3 | |
| 10893-120-10 | NaturasilCherry Angiomas | 1 in 1 BOTTLE, GLASS | LIQUID | 1 | 3 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| PHOSPHORIC ACID | ACTIVE INGREDIENT | E4GA8884NN | 1 | |
| PHOSPHORIC ACID | ACTIVE MOIETY | E4GA8884NN | 1 | |
| CHAMOMILE FLOWER OIL | INACTIVE INGREDIENT | 60F80Z61A9 | 1 | |
| GERANIUM OIL, ALGERIAN TYPE | INACTIVE INGREDIENT | 5Q1I94P4WG | 1 | |
| ISOPROPYL ALCOHOL | INACTIVE INGREDIENT | ND2M416302 | 1 | |
| LAVENDER OIL | INACTIVE INGREDIENT | ZBP1YXW0H8 | 1 | |
| ORANGE OIL | INACTIVE INGREDIENT | AKN3KSD11B | 1 | |
| PALMAROSA OIL | INACTIVE INGREDIENT | 0J3G3O53ST | 1 |
Products#
Every source-derived product name is available through these pages.
- Naturasil Cherry Angiomas
- Phosphoricum Acidum
- PHOSPHORIC ACID
- CHAMOMILE FLOWER OIL
- PALMAROSA OIL
- ISOPROPYL ALCOHOL
- LAVENDER OIL
- ORANGE OIL
- GERANIUM OIL, ALGERIAN TYPE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 10893-120 | 10893-120-10 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| PHOSPHORIC ACID | E4GA8884NN | ACTIB |
| CHAMOMILE FLOWER OIL | 60F80Z61A9 | IACT |
| PALMAROSA OIL | 0J3G3O53ST | IACT |
| ISOPROPYL ALCOHOL | ND2M416302 | IACT |
| LAVENDER OIL | ZBP1YXW0H8 | IACT |
| ORANGE OIL | AKN3KSD11B | IACT |
| GERANIUM OIL, ALGERIAN TYPE | 5Q1I94P4WG | IACT |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| ISOPROPYL ALCOHOL | ISOPROPYL ALCOHOL | ND2M416302 | GEL / TOPICAL | 75 mg | ||
| ISOPROPYL ALCOHOL | ISOPROPYL ALCOHOL | ND2M416302 | SPONGE / TOPICAL | 4 %w/w | ||
| ISOPROPYL ALCOHOL | ISOPROPYL ALCOHOL | ND2M416302 | SOLUTION / TOPICAL | 40 %w/v | ||
| ISOPROPYL ALCOHOL | ISOPROPYL ALCOHOL | ND2M416302 | GEL, METERED / TOPICAL | 525 mg | ||
| ISOPROPYL ALCOHOL | ISOPROPYL ALCOHOL | ND2M416302 | LOTION, AUGMENTED / TOPICAL | 2070 mg | ||
| ISOPROPYL ALCOHOL | ISOPROPYL ALCOHOL | ND2M416302 | GEL, METERED / TOPICAL | 525 mg | ||
| ISOPROPYL ALCOHOL | ISOPROPYL ALCOHOL | ND2M416302 | SWAB / TOPICAL | 43.9 %w/w | ||
| ORANGE OIL | ORANGE OIL, COLD PRESSED | AKN3KSD11B | LIQUID / ORAL | 50 mg | ||
| ISOPROPYL ALCOHOL | ISOPROPYL ALCOHOL | ND2M416302 | SWAB / TOPICAL | 43.9 %w/w | ||
| ORANGE OIL | ORANGE OIL, COLD PRESSED | AKN3KSD11B | LIQUID / ORAL | 50 mg | ||
| ISOPROPYL ALCOHOL | ISOPROPYL ALCOHOL | ND2M416302 | SOLUTION / TOPICAL | 40 %w/v | ||
| ISOPROPYL ALCOHOL | ISOPROPYL ALCOHOL | ND2M416302 | OIL / TOPICAL | 72 mg | ||
| LAVENDER OIL | LAVENDER OIL | ZBP1YXW0H8 | GEL / TOPICAL | 0.1 %w/w | ||
| ISOPROPYL ALCOHOL | ISOPROPYL ALCOHOL | ND2M416302 | OIL / TOPICAL | 72 mg | ||
| LAVENDER OIL | LAVENDER OIL | ZBP1YXW0H8 | GEL / TOPICAL | 0.1 %w/w | ||
| ISOPROPYL ALCOHOL | ISOPROPYL ALCOHOL | ND2M416302 | LOTION, AUGMENTED / TOPICAL | 2070 mg | ||
| ISOPROPYL ALCOHOL | ISOPROPYL ALCOHOL | ND2M416302 | SPONGE / TOPICAL | 4 %w/w | ||
| ISOPROPYL ALCOHOL | ISOPROPYL ALCOHOL | ND2M416302 | GEL / TOPICAL | 75 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Naturasil Cherry Angiomas | PHOSPHORICUM ACIDUM | Nature's Innovation | b512f00e-7b3e-4c7b-a0e6-ebffd84b231f | 2021-01-14 | Warnings | 10893-120-10 10893-120 10893012010 302fc1b1-e4a6-4b73-a485-d7d423a8eec9 b512f00e-7b3e-4c7b-a0e6-ebffd84b231f |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
